• Cytokinetics (NASDAQ:CYTK) Earns Outperform Rating from Analysts at Royal Bank of Canada

    Source: Buzz FX / 08 Nov 2024 08:40:17   America/New_York


    Cytokinetics (NASDAQ:CYTK) Earns Outperform Rating from Analysts at Royal Bank of Canada Written by MarketBeat November 8, 2024 Share Link copied to clipboard. Research analysts at Royal Bank of Canada assumed coverage on shares of Cytokine
    Read more...
Share on,